Cargando…
A moderate response to plasmapheresis in nephrogenic systemic fibrosis
Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resona...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981399/ https://www.ncbi.nlm.nih.gov/pubmed/24765365 http://dx.doi.org/10.4081/cp.2011.e124 |
_version_ | 1782311039561367552 |
---|---|
author | Ustuner, Pelin Kose, Ozlem Karadag Gulec, A. Tulin Ozen, Ozlem |
author_facet | Ustuner, Pelin Kose, Ozlem Karadag Gulec, A. Tulin Ozen, Ozlem |
author_sort | Ustuner, Pelin |
collection | PubMed |
description | Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6(th) month. |
format | Online Article Text |
id | pubmed-3981399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | PAGEPress Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-39813992014-04-24 A moderate response to plasmapheresis in nephrogenic systemic fibrosis Ustuner, Pelin Kose, Ozlem Karadag Gulec, A. Tulin Ozen, Ozlem Clin Pract Case Report Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6(th) month. PAGEPress Publications 2011-11-29 /pmc/articles/PMC3981399/ /pubmed/24765365 http://dx.doi.org/10.4081/cp.2011.e124 Text en ©Copyright P. Ustuner et al., 2011 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy |
spellingShingle | Case Report Ustuner, Pelin Kose, Ozlem Karadag Gulec, A. Tulin Ozen, Ozlem A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title | A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title_full | A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title_fullStr | A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title_full_unstemmed | A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title_short | A moderate response to plasmapheresis in nephrogenic systemic fibrosis |
title_sort | moderate response to plasmapheresis in nephrogenic systemic fibrosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981399/ https://www.ncbi.nlm.nih.gov/pubmed/24765365 http://dx.doi.org/10.4081/cp.2011.e124 |
work_keys_str_mv | AT ustunerpelin amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT koseozlemkaradag amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT gulecatulin amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT ozenozlem amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT ustunerpelin moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT koseozlemkaradag moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT gulecatulin moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis AT ozenozlem moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis |